Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials

0

Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials
S. R. Durham, A. O. Birk and J. S. Andersen
Allergy Volume 66, Issue 1, pages 120–123, January 2011

Haga un comentario

Los campos con asteriscos (*) son obligatorios.

*

code